Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Vox Sanguinis|January 1, 1984
Thermal stability of human albumin measured by differential scanning calorimetry. II. Effects of isomers of N-acetyltryptophanate and tryptophanate, pH, reheating, and dimerizationP D Ross, J S Finlayson, A ShrakeTransfusion|January 1, 1980
Levels of anti-A and anti-B in commercial immune globulinsJ M Gordon, P Cohen, J S FinlaysonThe Journal of Biological Chemistry|September 20, 1975
Activation of human prothrombin by a procoagulant fraction from the venom of Echis carinatus. Identification of a high molecular weight intermediate with thrombin activityB R Franza, D L Aronson, J S FinlaysonJournal of Virology|September 1, 1985
Interaction between various polymerized human albumins and hepatitis B surface antigenM W Yu, J S Finlayson, J W ShihProceedings of the National Academy of Sciences of the United States of America|April 1, 1971
Epsilon-(gamma glutamyl) lysine in fibrin: lack of crosslink formation in Factor 13 deficiencyJ J Pisano, J S Finlayson, M P Peyton, et al.Journal of Medical Virology|January 1, 1981
Antibodies to hepatitis A virus in immune serum globulinL A Smallwood, E Tabor, J S Finlayson, et al.Developments in Biological Standardization|January 1, 1983
Standardization of the antibody to hepatitis A virus (anti-HAV) content of immunoglobulinR J Gerety, L A Smallwood, J S Finlayson, et al.The Journal of Clinical Investigation|September 1, 1971
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide releaseH R Gralnick, H M Givelber, J R Shainoff, et al.The Journal of Clinical Investigation|December 1, 1977
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasmaD L Aronson, L Stevan, A P Ball, et al.Transfusion|September 1, 1995
Fibrin sealant: summary of a conference on characteristics and clinical usesB M Alving, M J Weinstein, J S Finlayson, et al.Pageof 4